| Cecilia Magdalena Bahamon, MD | |
|
200 Boylston St Ste 301, Chestnut Hill, MA 02467-2008 | |
| (617) 731-3400 | |
| (617) 566-2224 |
| Full Name | Cecilia Magdalena Bahamon |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 7 Years |
| Location | 200 Boylston St Ste 301, Chestnut Hill, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700306651 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 288144 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New England Ob/gyn Associates,inc | 8628038734 | 14 |
News Archive
Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
Glooko, the leader in diabetes data management, today announced the results of its recent study which examined diabetes healthcare professionals' use of CGM data.
IsoRay, Inc. announced today that it has completed a license agreement with Hologic, Inc. for exclusive worldwide distribution rights to the GliaSite® radiation therapy system, the world's only FDA-cleared balloon catheter device used in the treatment of brain cancer. The system's balloon catheter is a landmark technology that allows physicians to treat more patients than ever before with brachytherapy or internal radiation and provides important benefits over other radiation treatment options.
The Centers for Disease Control and Prevention's latest report shows that infections from E. coli O157:H7, Salmonella, and Vibrio are all on the rise. E. coli cases reported to CDC's FoodNet rose 50 percent since 2004, and Vibrio, another potentially deadly pathogen in shellfish, rose a whopping 78 percent since FoodNet began (1996-1998).
› Verified 4 days ago
| Entity Name | New England Ob/gyn Associates,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093899346 PECOS PAC ID: 8628038734 Enrollment ID: O20041013000850 |
News Archive
Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
Glooko, the leader in diabetes data management, today announced the results of its recent study which examined diabetes healthcare professionals' use of CGM data.
IsoRay, Inc. announced today that it has completed a license agreement with Hologic, Inc. for exclusive worldwide distribution rights to the GliaSite® radiation therapy system, the world's only FDA-cleared balloon catheter device used in the treatment of brain cancer. The system's balloon catheter is a landmark technology that allows physicians to treat more patients than ever before with brachytherapy or internal radiation and provides important benefits over other radiation treatment options.
The Centers for Disease Control and Prevention's latest report shows that infections from E. coli O157:H7, Salmonella, and Vibrio are all on the rise. E. coli cases reported to CDC's FoodNet rose 50 percent since 2004, and Vibrio, another potentially deadly pathogen in shellfish, rose a whopping 78 percent since FoodNet began (1996-1998).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cecilia Magdalena Bahamon, MD 200 Boylston St Ste 301, Chestnut Hill, MA 02467-2008 Ph: (617) 731-3400 | Cecilia Magdalena Bahamon, MD 200 Boylston St Ste 301, Chestnut Hill, MA 02467-2008 Ph: (617) 731-3400 |
News Archive
Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
Glooko, the leader in diabetes data management, today announced the results of its recent study which examined diabetes healthcare professionals' use of CGM data.
IsoRay, Inc. announced today that it has completed a license agreement with Hologic, Inc. for exclusive worldwide distribution rights to the GliaSite® radiation therapy system, the world's only FDA-cleared balloon catheter device used in the treatment of brain cancer. The system's balloon catheter is a landmark technology that allows physicians to treat more patients than ever before with brachytherapy or internal radiation and provides important benefits over other radiation treatment options.
The Centers for Disease Control and Prevention's latest report shows that infections from E. coli O157:H7, Salmonella, and Vibrio are all on the rise. E. coli cases reported to CDC's FoodNet rose 50 percent since 2004, and Vibrio, another potentially deadly pathogen in shellfish, rose a whopping 78 percent since FoodNet began (1996-1998).
› Verified 4 days ago
Gail Anahid Guzelian, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 850 Boylston Street, Suite 575 Brigham Obstetrics And Gynecology Group, Chestnut Hill, MA 02467 Phone: 617-732-9100 | |
Dr. Zsuzsa Ilona Kovacs, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 822 Boylston St, Ste. 102, Chestnut Hill, MA 02467 Phone: 617-396-8866 Fax: 617-505-6102 | |
Abigail Rachel Burns, MD, MSW Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 Boylston St Ste 301, Chestnut Hill, MA 02467 Phone: 617-731-3400 Fax: 617-566-2224 | |
Dr. Aaron K Styer, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 300 Boylston St Ste 300, Chestnut Hill, MA 02467 Phone: 617-449-9750 Fax: 617-449-9751 | |
Evelyn B Marsh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Boylston St, Suite 301, Chestnut Hill, MA 02467 Phone: 617-731-3400 Fax: 617-566-2224 | |
Sandy J Falk, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 850 Boylston Street, Suite 575, Chestnut Hill, MA 02467 Phone: 617-732-9100 | |
Brianna S Keith, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 Boylston St Ste 301, Chestnut Hill, MA 02467 Phone: 617-731-3400 Fax: 617-566-2224 |